Alveofact

Alveofact

beractant

Manufacturer:

PT Dexa Medica

Distributor:

Glorious Dexa
Concise Prescribing Info
Contents
Phospholipid fraction from bovine lung (surfactant)
Indications/Uses
Preventive use in neonates w/ a high risk of resp distress syndrome (RDS).
Dosage/Direction for Use
Intratracheal Single dose of 1.2 mL/kg (equiv to 54 mg/kg) w/in the 1st hr after birth.
Contraindications
Special Precautions
Congenital infections in premature neonates. May deteriorate pulmonary function during concomitant under development of the lung; prolonged deficiency of amniotic fluid due to ruptured membranes or congenital renal function impairment.
ATC Classification
R07AA02 - natural phospholipids ; Belongs to the class of lung surfactants. Used in the treatment of respiratory diseases.
Presentation/Packing
Form
Alveofact lyophilized powd for susp (intratracheal) 45 mg/mL
Packing/Price
(+ pre-filled syringe w/ 1.2 mL solvent) 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in